Physician profile
Tracy L Lee
NPI 1467847475
$5,113.99
in general payments reported to CMS, 2019-2025
22 companies · $2,679 in 2025
The $2,679 reported for 2025 was more than what 88% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.15 · 2020: $128 · 2021: $176 · 2022: $68.69 · 2023: $745 · 2024: $1,300 · 2025: $2,679.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,179 · Food and Beverage: $1,839 · Long Term Medical Supply Or Device Loan: $706.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,179.03 |
| Food and Beverage | $1,839.08 |
| Long Term Medical Supply Or Device Loan | $706.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,144.73 | 2020-2025 | Ortholoc 2 Lapifuse, Ortholoc 3di, Hoffmann |
| Integra Lifesciences Corporation | $791.68 | 2019-2025 | Acell, Integra, Primatrix |
| Depuy Synthes Sales INC. | $251.25 | 2020-2025 | Motoband, N/A, Minibunion |
| Kerecis Limited | $122.03 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Smith+Nephew, INC. | $112.93 | 2021-2025 | Bone Anchors With Arthroscopic Delivery System, Collagenase Santyl |
| Medtronic, INC. | $111.86 | 2023-2025 | Intellis Adaptivestim |
| Paratek Pharmaceuticals, INC. | $81.28 | 2022-2025 | Nuzyra |
| Orthofix Medical, INC. | $70.73 | 2022-2024 | Physio-Stim |
| Ani Pharmaceuticals, INC. | $55.07 | 2023 | Purified Cortrophin Gel |
| Paragon 28, INC. | $52.51 | 2021-2024 | Jaws, Plating Portfolio |
| Averitas Pharma INC. | $47.06 | 2024-2025 | Qutenza |
| Kowa Pharmaceuticals America, INC. | $41.30 | 2023 | Seglentis |
| Zimmer Biomet Holdings, INC. | $38.10 | 2021 | |
| Treace Medical Concepts, INC. | $29.93 | 2024 | |
| Tactile Systems Technology INC | $28.96 | 2023-2025 | Flexitouch Plus, Entre Plus, Nimbl |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $26.69 | 2023 | Theragenesis Bilayer Wound Matrix |
| Solventum Corporation | $23.80 | 2025 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Abbott Laboratories | $23.72 | 2024 | Proclaim |
| Pacira Pharmaceuticals Incorporated | $19.79 | 2020 | |
| Boston Scientific Corporation | $14.68 | 2025 | Wavewriter Alpha Prime 16 |
| Linvatec Corporation | $14.26 | 2023 | Linvatec Extremities, Biobrace 23mm, Allograft Tissue |
| Acumed LLC | $11.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.